应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
PHGE.U BIOMX INC UNIT
已收盘 10-31 16:00:00 EDT
0.9000
+0.0000
0.00%
最高
0.9000
最低
0.9000
成交量
0.00
今开
0.9000
昨收
0.9000
日振幅
0.00%
总市值
161.06万
流通市值
124.55万
总股本
178.96万
成交额
0.00
换手率
0.00%
流通股本
138.39万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BiomX(PHGE.US)获Laidlaw & Co.首次覆盖，给予买入评级, 目标价2.50美元。
智通财经 · 05-28
BiomX(PHGE.US)获Laidlaw & Co.首次覆盖，给予买入评级, 目标价2.50美元。
HC Wainwright & Co.：重申BiomX(PHGE.US)评级，由买入调整至买入评级, 目标价2.00美元。
智通财经 · 05-21
HC Wainwright & Co.：重申BiomX(PHGE.US)评级，由买入调整至买入评级, 目标价2.00美元。
BiomX(PHGE.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.28美元，前值为-0.20美元。
智通财经 · 05-21
BiomX(PHGE.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.28美元，前值为-0.20美元。
HC Wainwright & Co.：重申BiomX(PHGE.US)评级，由买入调整至买入评级, 目标价2.00美元。
智通财经 · 04-22
HC Wainwright & Co.：重申BiomX(PHGE.US)评级，由买入调整至买入评级, 目标价2.00美元。
暂无数据
公司概况
公司名称：
BIOMX INC UNIT
所属市场：
NASDAQ
上市日期：
--
主营业务：
BiomX Inc.于2017年11月1日根据特拉华州法律成立。2019年10月28日，该公司与BiomX Ltd.合并，然后更名为BiomX Inc.。该公司正在开发天然和工程化的噬菌体混合物，旨在针对和消灭慢性疾病中的有害细菌，目前主要致力于囊性纤维化，并在较小程度上致力于特应性皮炎。该公司发现并验证专有细菌靶点，并针对这些靶点定制噬菌体组合物。
发行价格：
--
{"stockData":{"symbol":"PHGE.U","market":"US","secType":"STK","nameCN":"BIOMX INC UNIT","latestPrice":0.9,"timestamp":1730404800000,"preClose":0.9,"halted":0,"volume":0,"delay":0,"floatShares":1383941,"shares":1789584,"eps":-4.13889,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"10-31 16:00:00 EDT","open":0.9,"high":0.9,"low":0.9,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.13889,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730448000000},"adr":0,"adjPreClose":0.9,"volumeRatio":0},"requestUrl":"/m/hq/s/PHGE.U/tweets","defaultTab":"tweets","newsList":[{"id":"2438304450","title":"BiomX(PHGE.US)获Laidlaw & Co.首次覆盖，给予买入评级, 目标价2.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2438304450","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438304450?lang=zh_cn&edition=full","pubTime":"2024-05-28 23:45","pubTimestamp":1716911141,"startTime":"0","endTime":"0","summary":"BiomX(PHGE.US)获Laidlaw & Co.首次覆盖，给予买入评级, 目标价2.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282345429efa550c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282345429efa550c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","PHGE.U"],"gpt_icon":0},{"id":"2437475344","title":"HC Wainwright & Co.：重申BiomX(PHGE.US)评级，由买入调整至买入评级, 目标价2.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2437475344","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437475344?lang=zh_cn&edition=full","pubTime":"2024-05-21 23:44","pubTimestamp":1716306283,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申BiomX(PHGE.US)评级，由买入调整至买入评级, 目标价2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405212344438b208ebf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405212344438b208ebf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE.U","PHGE"],"gpt_icon":0},{"id":"2437494823","title":"BiomX(PHGE.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.28美元，前值为-0.20美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2437494823","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437494823?lang=zh_cn&edition=full","pubTime":"2024-05-21 17:25","pubTimestamp":1716283541,"startTime":"0","endTime":"0","summary":"BiomX(PHGE.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.28美元，前值为-0.20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405211725428b1f5f2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405211725428b1f5f2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","PHGE.U"],"gpt_icon":0},{"id":"2429094946","title":"HC Wainwright & Co.：重申BiomX(PHGE.US)评级，由买入调整至买入评级, 目标价2.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429094946","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429094946?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:45","pubTimestamp":1713782728,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申BiomX(PHGE.US)评级，由买入调整至买入评级, 目标价2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221845308b45d31b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221845308b45d31b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE.U","PHGE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomx.com","stockEarnings":[{"period":"1week","weight":-0.0526},{"period":"1month","weight":-0.3077},{"period":"3month","weight":-0.4},{"period":"6month","weight":-0.7581},{"period":"1year","weight":-0.7193},{"period":"ytd","weight":-0.6429}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0109},{"period":"3month","weight":0.0681},{"period":"6month","weight":0.1344},{"period":"1year","weight":0.3869},{"period":"ytd","weight":0.2203}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BiomX Inc.于2017年11月1日根据特拉华州法律成立。2019年10月28日，该公司与BiomX Ltd.合并，然后更名为BiomX Inc.。该公司正在开发天然和工程化的噬菌体混合物，旨在针对和消灭慢性疾病中的有害细菌，目前主要致力于囊性纤维化，并在较小程度上致力于特应性皮炎。该公司发现并验证专有细菌靶点，并针对这些靶点定制噬菌体组合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.181463},{"month":2,"riseRate":0.4,"avgChangeRate":-0.08432},{"month":3,"riseRate":0.4,"avgChangeRate":0.503623},{"month":4,"riseRate":0.4,"avgChangeRate":0.00704},{"month":5,"riseRate":0.6,"avgChangeRate":0.063126},{"month":6,"riseRate":0.2,"avgChangeRate":-0.064422},{"month":7,"riseRate":0.4,"avgChangeRate":-0.16542},{"month":8,"riseRate":0.4,"avgChangeRate":-0.049793},{"month":9,"riseRate":0.2,"avgChangeRate":-0.133507},{"month":10,"riseRate":0.4,"avgChangeRate":-0.145279},{"month":11,"riseRate":0,"avgChangeRate":-0.188019},{"month":12,"riseRate":0.4,"avgChangeRate":-0.039762}],"exchange":"NASDAQ","name":"BIOMX INC UNIT","nameEN":"BIOMX INC UNIT"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BIOMX INC UNIT(PHGE.U)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BIOMX INC UNIT(PHGE.U)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BIOMX INC UNIT,PHGE.U,BIOMX INC UNIT股票,BIOMX INC UNIT股票老虎,BIOMX INC UNIT股票老虎国际,BIOMX INC UNIT行情,BIOMX INC UNIT股票行情,BIOMX INC UNIT股价,BIOMX INC UNIT股市,BIOMX INC UNIT股票价格,BIOMX INC UNIT股票交易,BIOMX INC UNIT股票购买,BIOMX INC UNIT股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOMX INC UNIT(PHGE.U)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BIOMX INC UNIT(PHGE.U)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}